Improving the interpretation of measured PSA levels may improve the clinical utility of the test, saving some men invasive unnecessary biopsies whilst ensuring that men with high risk prostate cancers are identified and offered treatment appropriately. The gene discussed is KLK3; the disease is prostate carcinoma.